Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > QIXLEEF vs opioid

<< Previous

Bullboard Posts

Next >>

Comment by JohnnyRingo20on Jun 01, 2022 9:18am

100 Views

Post# 34722805

RE:QIXLEEF vs opioid

Golddetector wrote:
Recently published data on page 12 of phase 2 fda reborn trial showed at 30 minutes 34% QIXLEEF vs 38% opioid at 60minutes 65% QIXLEEF vs 66% opioid. These results are groundbreaking. It is against the most severe cancer pain that mean it can be used as alternative for everything else. The results also showed way more safety record.